To our knowledge, however, this is the first study in cHL to show that high proportions of IDO-1 and PD-L1 expressing TAMs from all TAMs predict worse FFTF independently from clinical risk factors. This evidence concerns the gene CD274 and classic Hodgkin lymphoma.